First Trust Advisors LP Equillium, Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.84 - $6.91 $214,111 - $305,684	-44,238 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.11 - $7.64 $8,155 - $12,193	-1,596 Reduced 3.48%	44,238 $261,000
Q1 2021 May 14, 2021	BUY	$5.03 - $10.5 $71,053 - $148,323	14,126 Added 44.55%	45,834 $328,000
Q4 2020 Feb 02, 2021	SELL	$3.48 - $6.58 $2,818 - $5,329	-810 Reduced 2.49%	31,708 $170,000
Q3 2020 Nov 05, 2020	BUY	$2.78 - $26.5 $90,400 - $861,727	32,518 New	32,518 $188,000

11.5M

38.1K

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $47.1M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.